Russell SJ - Search Results

1

Single-chain antibody-based gene therapy: inhibition of tumor growth by in situ production of phage-derived human antibody fragments blocking functionally active sites of cell-associated matrices.

Sanz L, Kristensen P, Blanco B, Facteau S, Russell SJ, Winter G, Alvarez-Vallina L. Sanz L, et al. Among authors: russell sj. Gene Ther. 2002 Aug;9(15):1049-53. doi: 10.1038/sj.gt.3301725. Gene Ther. 2002. PMID: 12101437

2

Selection of phage antibodies by binding affinity. Mimicking affinity maturation.

Hawkins RE, Russell SJ, Winter G. Hawkins RE, et al. Among authors: russell sj. J Mol Biol. 1992 Aug 5;226(3):889-96. doi: 10.1016/0022-2836(92)90639-2. J Mol Biol. 1992. PMID: 1507232

3

The contribution of contact and non-contact residues of antibody in the affinity of binding to antigen. The interaction of mutant D1.3 antibodies with lysozyme.

Hawkins RE, Russell SJ, Baier M, Winter G. Hawkins RE, et al. Among authors: russell sj. J Mol Biol. 1993 Dec 20;234(4):958-64. doi: 10.1006/jmbi.1993.1650. J Mol Biol. 1993. PMID: 8263942

4

A genetic approach to idiotypic vaccination.

Hawkins RE, Winter G, Hamblin TJ, Stevenson FK, Russell SJ. Hawkins RE, et al. Among authors: russell sj. J Immunother Emphasis Tumor Immunol. 1993 Nov;14(4):273-8. doi: 10.1097/00002371-199311000-00004. J Immunother Emphasis Tumor Immunol. 1993. PMID: 8280708

5

Retroviral vectors displaying functional antibody fragments.

Russell SJ, Hawkins RE, Winter G. Russell SJ, et al. Nucleic Acids Res. 1993 Mar 11;21(5):1081-5. doi: 10.1093/nar/21.5.1081. Nucleic Acids Res. 1993. PMID: 8385311 Free PMC article.

6

A pilot study of idiotypic vaccination for follicular B-cell lymphoma using a genetic approach. CRC NO: 92/33. Protocol NO: PH1/027.

Hawkins RE, Russell SJ, Marcus R, Ashworth LJ, Brissnik J, Zhang J, Winter G, Bleehen NM, Shaw MM, Williamson L, Ouwehand W, Stevenson F, Hamblin T, Oscier D, Zhu D, King C, Kumar S, Thompsett A, Stevenson GT. Hawkins RE, et al. Among authors: russell sj. Hum Gene Ther. 1997 Jul 1;8(10):1287-99. doi: 10.1089/hum.1997.8.10-1287. Hum Gene Ther. 1997. PMID: 9215745 No abstract available.

7

Pharmacological control of antigen responsiveness in genetically modified T lymphocytes.

Alvarez-Vallina L, Agha-Mohammadi S, Hawkins RE, Russell SJ. Alvarez-Vallina L, et al. Among authors: russell sj. J Immunol. 1997 Dec 15;159(12):5889-95. J Immunol. 1997. PMID: 9550385

8

Efficient discrimination between different densities of target antigen by tetracycline-regulatable T bodies.

Alvarez-Vallina L, Russell SJ. Alvarez-Vallina L, et al. Among authors: russell sj. Hum Gene Ther. 1999 Mar 1;10(4):559-63. doi: 10.1089/10430349950018634. Hum Gene Ther. 1999. PMID: 10094199

9

Pharmacologic suppression of target cell recognition by engineered T cells expressing chimeric T-cell receptors.

Alvarez-Vallina L, Yañez R, Blanco B, Gil M, Russell SJ. Alvarez-Vallina L, et al. Among authors: russell sj. Cancer Gene Ther. 2000 Apr;7(4):526-9. doi: 10.1038/sj.cgt.7700128. Cancer Gene Ther. 2000. PMID: 10811469

10

Generation and characterization of recombinant human antibodies specific for native laminin epitopes: potential application in cancer therapy.

Sanz L, Kristensen P, Russell SJ, Ramirez García JR, Alvarez-Vallina L. Sanz L, et al. Among authors: russell sj. Cancer Immunol Immunother. 2001 Dec;50(10):557-65. doi: 10.1007/s00262-001-0235-5. Cancer Immunol Immunother. 2001. PMID: 11776378 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

637 results

Search Page